US PATH LABS LLC
BOCA RATON, FLORIDA

US Path Labs LLC is a distinguished provider of specimen preparation services based in Boca Raton, Florida. Established on March 9, 2004, the company specializes in dermatopathology and ensures all specimens processed in its lab are reviewed by Board Certified Dermatopathologists. US Path Labs is incorporated as an FLAL type entity with the filing number L04000018422, and it operates under the administration of pathology Holdings, LLC. The firm takes pride in its meticulous approach to specimen preparation, reflecting its commitment to quality and expertise in dermatological diagnostics. Located at 4910 Communications Ave, Boca Raton, FL, US Path Labs is a recognized entity within Palm Beach County. For those looking for further details or inquiries, the company can be contacted through their main phone lines: (866) 650-0276, (561) 989-0027, and (561) 989-0052. More information about their services and updates on their latest annual reports are available on their official website at uspathlabs.com. US Path Labs maintains a strong presence in the medical field with significant events noted, such as the amendment and restatement of its articles dated May 14, 2004.

KEY FACTS ABOUT US PATH LABS LLC

Company name
US PATH LABS LLC
Status
Active
Filed Number
L04000018422
FEI Number
562441251
Date of Incorporation
March 9, 2004
Age - 22 years
Home State
FL
Company Type
Florida Limited Liability

CONTACTS

Website
http://uspathlabs.com
Phones
(866) 650-0276
(561) 989-0027
(561) 989-0052

US PATH LABS LLC NEAR ME

Principal Address
4910 COMMUNICATIONS AVE,
BOCA RATON,
FL,
33431,
UN

See Also

Officers and Directors

The US PATH LABS LLC managed by the one company from BOCA RATON on following positions: Manager

PATHOLOGY HOLDINGS, LLC

Position
Manager Active
Address
4700 EXCHANGE COURT, SUITE 110, BOCA RATON, FL, 33431





Registered Agent is CORPORATE CREATIONS NETWORK, INC.

Address
801 US HIGHWAY 1, NORTH PALM BEACH, FL, 33408

Events

May 14, 2004
AMENDED AND RESTATEDARTICLES

Annual Reports

2025
February 19, 2025
2024
April 22, 2024